← Back to Clinical Trials
Recruiting NCT07756775

NCT07756775 Comparison Between Non-contrast Magnetic Resonance Angiography and Carotid Doppler in Cerebrovascular Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07756775
Status Recruiting
Phase
Sponsor Sohag University
Condition Ischemic Stroke
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2026-07-20
Primary Completion 2027-02-28

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2026-07-20 with a primary completion date of 2027-02-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This prospective observational study aims to compare the diagnostic performance of non-contrast magnetic resonance angiography (NC-MRA) and carotid Doppler ultrasonography in the evaluation of carotid artery disease among patients with ischemic cerebrovascular stroke or transient ischemic attack. A total of 200 adult patients presenting to Sohag University Hospital will undergo both imaging modalities. The study will assess the agreement between NC-MRA and carotid Doppler in detecting and grading carotid artery stenosis according to the NASCET criteria, with the goal of evaluating the clinical utility of each technique and optimizing imaging strategies for the assessment of cerebrovascular stroke.

Eligibility Criteria

Inclusion Criteria: * Adults aged 18 years or older. * Clinically diagnosed ischemic stroke or transient ischemic attack (TIA). * Imaging performed within 7-14 days of symptom onset. * Hemodynamically stable and suitable for magnetic resonance imaging (MRI). * Able and willing to provide written informed consent. Exclusion Criteria: * Hemorrhagic stroke. * Previous carotid artery stenting. * Contraindications to MRI, including: * Non-MRI-compatible pacemakers or other MRI-incompatible implants. * Cochlear implants. * MRI-incompatible metallic orthopedic implants. * Severe claustrophobia.

Contact & Investigator

Central Contact

Mohamed Saad Gad

✉ mohsaadgad@gmail.com

📞 +201112435154

Principal Investigator

Mohamed Tharwat Mahmoud, Professor

STUDY CHAIR

Sohag University

Frequently Asked Questions

Who can join the NCT07756775 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07756775 currently recruiting?

Yes, NCT07756775 is actively recruiting participants. Contact the research team at mohsaadgad@gmail.com for enrollment information.

Where is the NCT07756775 trial being conducted?

This trial is being conducted at Sohag, Egypt.

Who is sponsoring the NCT07756775 clinical trial?

NCT07756775 is sponsored by Sohag University. The principal investigator is Mohamed Tharwat Mahmoud, Professor at Sohag University. The trial plans to enroll 200 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology